Back
Medlander Jumps 20% On BCI Hype Despite No Sales
Back
Stock News
Themes
Medlander Jumps 20% On BCI Hype Despite No Sales
Medlander Jumps 20% On BCI Hype Despite No Sales
Edgen Stock
·
Jan 06 2026, 14:23
Share to
Share to
Copy link
source:
[1] Medlander (688273.SH): Products in the brain-computer interface field are still in the R&D and market cultivation stage and have not yet achieved large-scale sales
Recommend
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17
US-China AI Rivalry Enters New Phase Focused on Compute Power and Cybersecurity
Nov 28 2025, 10:17
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17